AN OUTDOOR PLAYGROUND &

formulation science technology hub.

We have a passion for innovating to help our pharma clients get their products to patients and the market. Since 1998 our team has been creating and developing drug delivery technologies and advancing formulation science to meet the needs of challenging molecules.

LEADERSHIP TEAM

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles 
  • Patent holder (3)
  • Leading innovative teams
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement & Particle Engineering
  • Process scale-up and scale down
  • Technology commercialization & CMC (5 products in 5 yrs)
  • Clinical manufacturing operations
  • 15 years industry experience
  • PhD – Chemical Engineering
  • Author numerous scientific and industry articles 
  • Patent holder (1)
  • Business strategy and portfolio management
  • Drug Delivery / Formulation Science
  • Bioavailability Enhancement and Particle Engineering
  • Developing program technical and CMC strategy
  • Technology commercialization
  • Client experience and communications
  • 13 years industry experience
  • MS – Chemistry
  • Author numerous scientific and industry articles 
  • Patent holder (5)
  • Drug product design and technical team leadership from formulation feasibility through clinical development and commercialization
  • Technology commercialization & CMC
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement and Modified Release
  • Tablet formulation science
  • Analytical Chemistry
  • 11 years industry experience
  • PhD – Physical Chemistry
  • Author numerous scientific and industry articles (70)
  • Patent holder (2)
  • Physical chemistry & material science fundamentals & application to portfolio programs
  • Drug Delivery / Formulation Science
  • Bioavailability Enhancement and Particle Engineering
  • Solid form characterization
  • 15 years industry experience
  • BS in Chemical Engineering
  • Early phase clinical operations and quality systems
  • Systems development & optimization
  • Inhalation particle engineering; biomolecule formulation
  • Drug delivery and formulation science
  • Bioavailability enhancement
  • 13 years of pharmaceutical industry experience
  • BA in Communications
  • Marketing – Social Media, Digital, Print, Content Creation, Strategy and PR
  • Conferences + Trade Shows
  • Events
  • 30+ years of industry experience
  • BS – Microbiology
  • Quality system development (investigations, deviations, CAPA, document control)​
  • Regulatory compliance​
  • Environmental monitoring​
  • Equipment and facility qualification and validation​
  • External and internal auditing​
  • 23 years in program management​
  • 5 years industry experience
  • BA Journalism​
  • Project Management Professional (PMP)
  • Client service and communications
  • Client relationship management
  • Business development
  • Early phase product development through phase 2 clinical project management
  • 25 years of GMP analytical experience from early clinical to commercial
  • 9 years management experience in CDMO
  • B.S. Forensic Science
  • Method Development/Validation
  • Audit response
  • Laboratory Investigations
  • Deviation Reduction

Ajay Damani is Chief Executive Officer and a member of the Board of Directors of CoreRx since October 2021. Ajay brings over 20 years of experience in the life sciences industry across business development and marketing, M&A and licensing, and product development. Prior to joining CoreRx, Ajay led the Pharmaceutical Technologies business unit at Adare Pharmaceuticals, and was a member of the executive leadership team. Previously, Ajay led the Global Pharmaceutical Business Development organization at Capsugel, and led commercial integration efforts once the company was acquired by Lonza.

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles
  • Patent holder (16)
  • Business strategy and portfolio management
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement and Particle Engineering
  • Strategic Planning, Strategic Business Deals, Pricing, Market Offering,  Portfolio Optimization

OUR CoreRx LEADERSHIP TEAM

Owen Murray

Chief Executive Officer

 

As Chief Executive Officer and President, Mr. Owen Murray leads Bend Bioscience in its mission to ‘amplify the potential of medicine.’ He is responsible for strategy development and executive function of Bend Bioscience with a passion for scientific value creation. He has over 25 years of experience in the global pharmaceutical and healthcare industry encompassing early product development through commercialization within Innovator and CDMO businesses.
He most recently served as the Chief Executive Officer at Aprecia Pharmaceuticals. Before joining Aprecia, Mr. Murray held varying positions of increasing responsibility at Recordati Rare Diseases, Cardinal Health, Lundbeck, and Ovation Pharmaceuticals in the EU and US.
Mr. Murray received his B.Sc. in Biochemistry with honors from the University of Wales, Swansea. He earned his MBA with a management concentration from Seton Hall University and has an MSc in Healthcare Leadership from Brown University. Mr. Murray holds numerous international patents.

Gwen Green

Chief Commercial Officer

 

Gwen Green brings a wealth of experience in commercial excellence, strategy, and leadership within the pharmaceutical and biotech sectors.   She is responsible for overseeing sales, marketing, and business development strategies to maximize our market share. Prior to joining Bend Bioscience, Gwen held various leadership positions for Catalent, Cardinal Health, and PCI and has a proven record for driving business growth, cross-functional engagement, and development of employees.

Gwen holds a BS, Nutrition and Science from The Pennsylvania State University and currently serves on the Board of Directors for National Tay Sachs and Allied Diseases Association of Delaware Valley (NTSAD-DV).

Sandra Mathis

Head of Human Resources

 

Sandra brings over 20 years of progressive leadership experience in Human Resources within the pharmaceutical industry, navigating diverse organizational landscapes, including mergers & acquisitions, unionized environments, startups, and company closures.  She serves as a trusted advisor to the executive team, providing strategic guidance and addressing key organizational challenges. Sandra has served in several key HR leadership roles, including Vice President of Human Resources at SCN BestCo, Senior Director of HR at Societal CDMO (formerly Recro CDMO), and Site HR Manager for Noramco/Janssen Pharmaceuticals.

She holds an MBA in Business Management, Operations and Organizational Behavior from Southern Methodist University, and a BBA in Management and Human Resources from Texas A&M University.

Dana Settel

Bend Bioscience Founder

Site Head

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles
  • Patent holder (3)
  • Leading innovative teams
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement & Particle Engineering
  • Process scale-up and scale down
  • Technology commercialization & CMC (5 products in 5 yrs)
  • Clinical manufacturing operations

Dana Settel

Bend Bioscience Founder

Site Head

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles
  • Patent holder (3)
  • Leading innovative teams
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement & Particle Engineering
  • Process scale-up and scale down
  • Technology commercialization & CMC (5 products in 5 yrs)
  • Clinical manufacturing operations

Dana Settel

Bend Bioscience Founder

Site Head

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles
  • Patent holder (3)
  • Leading innovative teams
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement & Particle Engineering
  • Process scale-up and scale down
  • Technology commercialization & CMC (5 products in 5 yrs)
  • Clinical manufacturing operations

Jacob Werlinger

Chief Operating Officer

 

Jacob is an accomplished executive and  a multi-disciplined leader with more than 28 years of experience in manufacturing, quality, program management, research & development, commercial and supply chain all in the pharmaceutical and contract manufacturing industry.  He has played a pivotal role in optimizing  processes, ensuring the timely delivery of high-quality products, and fostering essential relationships with key stakeholders. His leadership has been instrumental in enhancing the overall performance and growth of the organizations he led.  Jacob’s leadership strategy focuses on integrating people, processes, and technology to achieve organizational success. He believes in empowering his team through continuous learning and development, fostering a culture of collaboration and innovation. By leveraging these techniques, Jacob has streamlined operations and improved decision-making processes, resulting in increased efficiency and productivity.

Prior to Bend Jacob had various levels of increasing responsibilities at Abbott Laboratories, and Hospira Inc. and most recently as the Vice President of Supply Chain at Merz Aesthetics

Jacob holds a degree from University Wisconsin – LaCrosse and certifications in Leadership (Harvard Leadership Academy) and Buisnes Management (Lake Forest School of Management).

Dan Dobry

Chief Strategic Officer

 

Dan has greater than 25 years of experience as a global CDMO business leader and drug delivery innovator and has contributed to process and formulation development, particle engineering and materials science innovations resulting in more than 15 patents.  Dan’s experience in the pharma services industry spans manufacturing science and technology, product development, alliance management, corporate development. Prior to joining CoreRx, Dan held leadership roles in Commercial Development at Lonza, Strategic Alliance Management at Capsugel, and as the Vice President of Engineering for Bend Research, Inc.

 

Dan earned a Bachelor of Sciences degree in Chemical Engineering at Oregon States University.

Anders Forsell

Chief Financial Officer

 

Anders Forsell brings years of experience in Private Equity and CPG organizations, with a primary focus on strategic planning, M&A, manufacturing efficiencies, and financial modeling & analysis supporting profitable revenue growth. Prior to joining Bend Bioscience, Anders held leadership roles at Cott Corporation, including CFO of North America, and member of the Executive Team. Most recently Anders held the role of Chief Financial Officer at OttLite Technologies.

Anders earned a Masters degree in Business at the University of Central Florida.

Dana Settel

Bend Bioscience Founder

Site Head

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles
  • Patent holder (3)
  • Leading innovative teams
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement & Particle Engineering
  • Process scale-up and scale down
  • Technology commercialization & CMC (5 products in 5 yrs)
  • Clinical manufacturing operations

Dana Settel

Bend Bioscience Founder

Site Head

  • 23 years industry experience
  • BS – Chemical Engineering
  • Author numerous scientific and industry articles
  • Patent holder (3)
  • Leading innovative teams
  • Drug Delivery and Formulation Science
  • Bioavailability Enhancement & Particle Engineering
  • Process scale-up and scale down
  • Technology commercialization & CMC (5 products in 5 yrs)
  • Clinical manufacturing operations